ResearchMoz

USA Cardiovascular Devices Market Trends and Forecast (2010 - 2015)

Renub Research
Published Date » 2011-10-05
No. Of Pages » 72

USA Cardiovascular Device - Market Overview

One in three American adults has some form of Cardiovascular Disease (CVD). Heart disease and stroke are the most common cardiovascular diseases. These are the first and third leading causes of death for both men and women in the United States. Cardiovascular Disease includes high blood pressure, coronary heart disease, heart failure and stroke. It is the leading cause of death in America and the World.

United States cardiovascular devices market is expected to be over US$ 35 Billion by 2015, with a compound annual growth rate of approximately 7% from the period of 2011 to 2015. The cardiovascular device market is expected to be driven by increase in the incidence of cardiovascular diseases, an ageing population and greater adoption of technological advancements.

The most rapidly growing segments in the cardiovascular device market are interventional cardiology, cardiac rhythm management, and cardiovascular prosthetic device market. Cardiac Rhythm Management devices market is one of the major contributing segments expected to generate more than US$ 16 Billion by 2015. Interventional cardiology devices represent one of the fastest developing areas in the overall cardiovascular device market which is expected to touch US$ 12 Billion by 2015. 

An increasing demand for minimally invasive surgeries amongst the rapidly aging population is expected to spark further growth in the cardiovascular devices market. Moreover, the cost efficiencies offered by lesser invasive methods expect to garner much favor amongst the healthcare payers in the coming years.
Table of Contents

1. Executive Summary

2. United States Cardiovascular Device Market & Forecast (2006 - 2015)

3. United States Cardiovascular Device Market & Forecast (2006 - 2015)
3.1 Cardiac Rhythm Management
3.1.1 Implantable Cardioverter Defibrillator
3.1.2 Pacemaker
3.1.3 Cardiac Resynchronization Therapy-Pacemaker (CRT-P)
3.2 Interventional Cardiology
3.2.1 Angioplasty
3.2.2 Angiography
3.2.3 PTCA Balloon
3.2.4 Coronary Stent
3.3 Cardiovascular Surgery
3.3.1 Anastomosis Device
3.3.2 Endoscopic Vessel Harvesting Device
3.3.3 Ventricular Assist Device (VAD)
3.3.4 Heart Valve
3.4 Cardiovascular Prosthetic Device
3.4.1 Prosthetic Heart Valve
3.5 Peripheral Vascular Device
3.6 Cardiovascular Monitoring & Diagnostic Device

4. Growth Drivers in Cardiovascular Device Market
4.1 Aging of the Population
4.2 Obesity
4.3 Smoking
4.4 High Incidence of Cardiovascular Death

5. Challenges
5.1 Significance of Cardiovascular Device Innovation
5.2 Regulation

6. Merger & Acquisition in Cardiovascular Device Market

7. Key Companies
7.1 Sorin
7.1.1 Globally - Sorin Revenue from Cardiovascular Devices
7.1.2 Strength
7.1.3 Weaknesses
7.2 Edwards Lifesciences
7.2.1 Global - St. Edwards Revenue from Cardiovascular Devices
7.2.2 United States - St. Edwards Revenue from Cardiovascular Devices
7.2.3 Strength
7.2.4 Weaknesses
7.3 St. Jude Medical
7.3.1 Globally - St. Jude Revenue from Medical Cardiovascular Devices
7.3.2 Strength
7.3.3 Weaknesses
7.4 Medtronic
7.4.1 Globally - Medtronic Revenue from Cardiovascular Devices
7.4.2 Strength
7.4.3 Weaknesses

List of Tables


Table 4 1: Global - Population aged 60 or over, 65 or over and 80 or over by Sex (Thousands)
Table 4 2: Worldwide - Prevalence of Adult Obesity for Developed Countries (Percent %), 2002 - 2005
Table 4 3: Worldwide - Prevalence of Adult Obesity for Developing Countries (Percent %), 1998 - 2005
Table 4 4: United States - Deaths from Cardiovascular Diseases (Thousand), 1900 - 2007
Table 4 5: United States - Forecast for Crude Prevalence (Percent), 2010, 2015, 2020, 2025, 2030
Table 4 6: United States - Forecast for Direct (Medical) costs (Billion US$), 2010, 2015, 2020, 2025, 2030
Table 4 7: United States - Forecast for Indirect (lost productivity) costs (Billion US$), 2010, 2015 2020, 2025, 2030
Table 6 1: Worldwide - Merger & Acquisition (Million US$), 1998 - 2010

List of Figures


Figure 2 1: United States - Cardiovascular Device Market (Million US$), 2006 - 2010
Figure 2 2: United States - Forecast for Cardiovascular Device Market (Million US$), 2011 - 2015
Figure 3 1: United States - Cardiac Rhythm Management Market (Million US$), 2006 - 2010
Figure 3 2: United States - Forecast for Cardiac Rhythm Management Market (Million US$), 2011 - 2015
Figure 3 3: United States - Implantable Cardioverter Defibrillator Market (Million US$), 2003 - 2010
Figure 3 4: United States - Forecast for Implantable Cardioverter Defibrillator Market (Million US$), 2011 - 2015
Figure 3 5: United States - Pacemaker Market (Million US$), 2003 - 2010
Figure 3 6: United States - Forecast for Pacemaker Market (Million US$), 2011 - 2015
Figure 3 7: United States - CRT-P Market (Million US$), 2005 - 2010
Figure 3 8: United States - Forecast for CRT-P Market (Million US$), 2011 - 2015
Figure 3 9: United States - Interventional Cardiology Market (Million US$), 2006 - 2010
Figure 3 10: United States - Forecast for Interventional Cardiology Market (Million US$), 2011 - 2015
Figure 3 11: United States - Angioplasty Market (Million US$), 2003 - 2010
Figure 3 12: United States - Forecast for Angioplasty Market (Million US$), 2011 - 2015
Figure 3 13: United States - Angiography Market (Million US$), 2003 - 2010
Figure 3 14: United States - Forecast for Angiography Market (Million US$), 2011 - 2015
Figure 3 15: United States - PTCA Balloon Market (Million US$), 2003 - 2010
Figure 3 16: United States - Forecast for PTCA Balloon Market (Million US$), 2011 - 2015
Figure 3 17: United States - Coronary Stent Market (Million US$), 2003 - 2010
Figure 3 18: United States - Forecast for Coronary Stent Market (Million US$), 2011 - 2015
Figure 3 19: United States - Cardiovascular Surgery Market (Million US$), 2006 - 2010
Figure 3 20: United States - Forecast for Cardiovascular Surgery Market (Million US$), 2011 - 2015
Figure 3 21: United States - Forecast for Anastomosis Device Market (Million US$), 2011 - 2015
Figure 3 22: United States - Endoscopic Vessel Harvesting Market (Million US$), 2003 - 2010
Figure 3 23: United States - Forecast for Endoscopic Vessel Harvesting Market (Million US$), 2011 - 2015
Figure 3 24: United States - Ventricular Assist Device Market (Million US$), 2004 - 2010
Figure 3 25: United States - Forecast for Ventricular Assist Device Market (Million US$), 2011 - 2015
Figure 3 26: United States - Heart Valve Market (Million US$), 2004 - 2010
Figure 3 27: United States - Forecast for Heart Valve Market (Million US$), 2011 - 2015
Figure 3 28: United States - Cardiovascular Prosthetic Market (Million US$), 2006 - 2010
Figure 3 29: United States - Forecast for Cardiovascular Prosthetic Market (Million US$), 2011 - 2015
Figure 3 30: United States - Prosthetic Heart Valve Market (Million US$), 2008 - 2010
Figure 3 31: United States - Forecast for Prosthetic Heart Valve Market (Million US$), 2011 - 2015
Figure 3 32: United States - Peripheral Vascular Market (Million US$), 2006 - 2010
Figure 3 33: United States - Forecast for Peripheral Vascular Market (Million US$), 2011 - 2015
Figure 3 34: United States - Cardiovascular Monitoring & Diagnostic Market (Million US$), 2006 - 2010
Figure 3 35: United States - Forecast for Cardiovascular Monitoring & Diagnostic Market (Million US$), 2011 - 2015
Figure 4 1: Population Aged 60 or over: World & Development Regions, 1950 - 2050
Figure 4 2: Old-age Dependency Ratio: Major Areas, 2009 & 2050
Figure 7 1: Global - Sorin Cardiovascular Devices Revenue (Million US$), 2008 - 2010
Figure 7 2: Global - St Edwards Cardiovascular Devices Revenue (Million US$), 2008 - 2010
Figure 7 3: United States - St Edwards Cardiovascular Devices Revenue (Million US$), 2008 - 2010
Figure 7 4: Global - St Jude Medical Cardiovascular Devices Revenue (Million US$), 2007 - 2010
Figure 7 5: Global - Medtronic Cardiovascular Devices Revenue (Million US$), 2007 - 2010

Upcoming Reports:

Life Sciences and Analytical Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Life science and analytical reagents are those compounds and substances which are used to detect and create a new substance with the purpose of making them available for test reading and are also known as biotechnology reagents. Such reagents are significant in the areas of research, bioscience, diagnosis and education. This market is driven by factors such as expansion in the use of reagents in the field of therapeutics, growth in research and rapid commercialization of such products. The growth in the field of biotechnology instrumentation also influences the demand for...
Food Container Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The global food container market is expected to grow in the coming years as a result of increase in global food output and the increasing trend toward convenience-oriented food options because of the changing lifestyles. In addition, the rising trend of women in workforce, increasing urban population, and rise in single person households are fuelling the growth of food container industry.  Plastic containers are expected to witness the highest growth rate as they offer numerous advantages over glass, metal, and paperboard containers. Bag and pouch prospects will benefit...
Microgrids Market- Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012-2018
By - Transparency Market Research
Factors such as increasing demand and cost of energy along with ageing energy infrastructure are driving microgrid market globally. Microgrid market is expected to grow at a CAGR of 13.7% during the period of 2012-2018. With advantages such as fewer line losses, lower demand of infrastructure and the ability to rely on more localized sources of power generation, microgrid is gaining more popularity in commercial, military and industrial sectors. Microgrid is the integrated system of distributed energy resources operating as a single grid. It is a smaller version of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...